Distribution of 76Br-labeled antisense oligonucleotides of different length determined ex vivo in rats
- 12 April 2000
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 10 (3) , 179-186
- https://doi.org/10.1016/s0928-0987(00)00067-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical TrialHuman Gene Therapy, 1999
- Correlation of Toxicity and Pharmacokinetic Properties of a Phosphorothioate Oligonucleotide Designed to Inhibit ICAM-1Toxicologic Pathology, 1999
- Gene therapy for the treatment of AIDS: animal models and human clinical experienceFrontiers in Bioscience-Landmark, 1999
- Treatment of rheumatoid arthritis with IL-1 inhibitorsSpringer Seminars in Immunopathology, 1998
- Toxicologic Effects of an Oligodeoxynucleotide Phosphorothioate and Its Analogs Following Intravenous Administration in RatsAntisense and Nucleic Acid Drug Development, 1997
- Perspectives in antisense therapeuticsPharmacology & Therapeutics, 1997
- Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studiesProceedings of the National Academy of Sciences, 1997
- Distribution of the Cellular Uptake of Phosphorothioate Oligodeoxynucleotides in the Rat Kidney in vivoNephron, 1997
- Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociceptionNeuroReport, 1996
- Whole-body autoradiography using 11C with double-tracer applicationsThe International Journal of Applied Radiation and Isotopes, 1984